4,097
Views
5
CrossRef citations to date
0
Altmetric
Surgery

Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United States

, , &
Pages 514-523 | Received 03 Mar 2021, Accepted 06 Apr 2021, Published online: 29 Apr 2021

References

  • Boucher BA, Traub O. Achieving hemostasis in the surgical field. Pharmacotherapy. 2009;29(7, part 2):2S–7S.
  • Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion. 2004;44(10):1453–1462.
  • Renkens KL, Jr Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976)). 2001;26(15):1645–1650.
  • Block JE. Severe blood loss during spinal reconstructive procedures: the potential usefulness of topical hemostatic agents. Med Hypotheses. 2005;65(3):617–621.
  • Bochicchio G, Dunne J, Bochicchio K, et al. The combination of platelet-enriched autologous plasma with bovine collagen and thrombin decreases the need for multiple blood transfusions in trauma patients with retroperitoneal bleeding. J Trauma Acute Care Surg. 2004;56(1):76–79.
  • Tomizawa Y. Clinical benefits and risk analysis of topical hemostats: a review. J Artif Organs. 2005;8(3):137–142.
  • Galas FR, Almeida JP, Fukushima JT, et al. Blood transfusion in cardiac surgery is a risk factor for increased hospital length of stay in adult patients. J Cardiothorac Surg. 2013;8(1):54.
  • Slonim AD, Joseph JG, Turenne WM, et al. Blood transfusions in children: a multi-institutional analysis of practices and complications. Transfusion. 2008;48(1):73–80.
  • McDonnell MF, Glassman SD, John R, Dimar I, et al. Perioperative complications of anterior procedures on the spine. JBJS. 1996;78(6):839–847.
  • Carreon LY, Puno RM, Dimar JR, et al. Perioperative complications of posterior lumbar decompression and arthrodesis in older adults. JBJS. 2003;85(11):2089–2092.
  • Lewis KM, Atlee HD, Mannone AJ, et al. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Investig Surg. 2013;26(3):141–148.
  • Mozet C, Prettin C, Dietze M, et al. Use of Floseal and effects on wound healing and pain in adults undergoing tonsillectomy: randomised comparison versus electrocautery. Eur Arch Otorhinolaryngol. 2012;269(10):2247–2254.
  • Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg. 2009;88(5):1520–1526.
  • Raga F, Sanz-Cortes M, Bonilla F, et al. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. Fertil Steril. 2009;92(1):356–360.
  • Samudrala S. Topical hemostatic agents in surgery: a surgeon's perspective. Aorn J. 2008; 88(3):S2–S11.
  • Lundblad RL, Bradshaw RA, Gabriel D, et al. A review of the therapeutic uses of thrombin. Thromb Haemost. 2004;91(05):851–860.
  • Shander A, Kaplan LJ, Harris MT, et al. Topical hemostatic therapy in surgery: bridging the knowledge and practice gap. J Am Coll Surg. 2014;219(3):570–579. e4.
  • Danker W, III DeAnglis A, Ferko N, et al. Comparison of fibrin sealants in peripheral vascular surgery: A systematic review and network meta-analysis. Ann Med Surg. 2021;61:161–168.
  • Moss R. Management of Surgical Hemostasis: An Independent Study Guide 2013. Available from: https://www.aorn.org/-/media/aorn/guidelines/tool-kits/medication-safety/management-of-surgical-hemostasis-independent-study-guide.pdf?la=en&hash=9FED3DF8BFDEF8B1C8D1899F8FC7BE79.
  • Oz MC, Cosgrove DM, III Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg. 2000;69(5):1376–1382.
  • Maisano F, Kjaergård HK, Bauernschmitt R, et al. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial. Eur J Cardio-Thorac Surg. 2009;36(4):708–714.
  • Tackett SM, Calcaterra D, Magee G, et al. Real-world outcomes of hemostatic matrices in cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28(6):1558–1565.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Clin Epidemiol. 1987;40(5):373–383.
  • Team RC. R: a language and environment for statistical computing. Vienna: The R Foundation, 2017. 2020.
  • Ramirez MG, Deutsch H, Khanna N, et al. FLOSEAL only versus in combination in spine surgery: A comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes. Hosp Prac. 2018;46(4):189–196.
  • Lewis KM, Li Q, Jones DS, et al. Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents. Surgery. 2017;161(3):771–781.
  • Tackett SM, Sugarman R, Kreuwel HT, et al. Hospital economic impact from hemostatic matrix usage in cardiac surgery. J Med Econ. 2014;17(9):670–676.